Ruchi Sharma | CEO
Stemnovate Limited

Ruchi Sharma is the CEO of Stemnovate Limited, a biotechnology company focusing on stem cell research and drug discovery. With a PhD from the University of Edinburgh and research experience at the University of Cambridge, she founded Stemnovate to develop solutions for rare diseases and alternatives to animal testing. Under her leadership, Stemnovate has emerged as a key player in the orphan drug sector, advancing personalised medicine and precision therapies. Dr. Sharma has been recognised among the Top 21 leaders in biotechnology research in Cambridge and actively participates in international collaborations. Stemnovate has launched products in ten countries and is developing partnerships with leading pharmaceutical companies, including a project targeting rare mitochondrial diseases.  Ruchi's dedication to making a meaningful impact in the lives of patients with rare diseases is evident in her work at Stemnovate Limited. Through her leadership, the company is poised to continue driving advancements in regenerative medicine and bringing hope to individuals and families affected by orphan diseases.